sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantation
CONCLUSION: VEGF-R1 levels are found to be increased in pediatric patients developing SOS, reflecting the severity of morbidity. sVEGF-R1 were unassociated with both CLS and ES. The potential of sVEGF-R1 as a clinically useful biomarker for SOS should be further explored to improve pre-transplant SOS-risk assessment, SOS-severity grading, and to guide treatment.PMID:38122992 | DOI:10.1016/j.trim.2023.101975 (Source: Transplant Immunology)
Source: Transplant Immunology - December 20, 2023 Category: Transplant Surgery Authors: Denise Elb æk Horan Katrine Kielsen Sarah Wegener Weischendorff Maria Ebbesen S ørum Marte B Kammersgaard Marianne Ifversen Claus Nielsen Lars P Ryder P är I Johansson Klaus M üller Source Type: research
sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantation
CONCLUSION: VEGF-R1 levels are found to be increased in pediatric patients developing SOS, reflecting the severity of morbidity. sVEGF-R1 were unassociated with both CLS and ES. The potential of sVEGF-R1 as a clinically useful biomarker for SOS should be further explored to improve pre-transplant SOS-risk assessment, SOS-severity grading, and to guide treatment.PMID:38122992 | DOI:10.1016/j.trim.2023.101975 (Source: Transplant Immunology)
Source: Transplant Immunology - December 20, 2023 Category: Transplant Surgery Authors: Denise Elb æk Horan Katrine Kielsen Sarah Wegener Weischendorff Maria Ebbesen S ørum Marte B Kammersgaard Marianne Ifversen Claus Nielsen Lars P Ryder P är I Johansson Klaus M üller Source Type: research
sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantation
CONCLUSION: VEGF-R1 levels are found to be increased in pediatric patients developing SOS, reflecting the severity of morbidity. sVEGF-R1 were unassociated with both CLS and ES. The potential of sVEGF-R1 as a clinically useful biomarker for SOS should be further explored to improve pre-transplant SOS-risk assessment, SOS-severity grading, and to guide treatment.PMID:38122992 | DOI:10.1016/j.trim.2023.101975 (Source: Transplant Immunology)
Source: Transplant Immunology - December 20, 2023 Category: Transplant Surgery Authors: Denise Elb æk Horan Katrine Kielsen Sarah Wegener Weischendorff Maria Ebbesen S ørum Marte B Kammersgaard Marianne Ifversen Claus Nielsen Lars P Ryder P är I Johansson Klaus M üller Source Type: research
sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantation
CONCLUSION: VEGF-R1 levels are found to be increased in pediatric patients developing SOS, reflecting the severity of morbidity. sVEGF-R1 were unassociated with both CLS and ES. The potential of sVEGF-R1 as a clinically useful biomarker for SOS should be further explored to improve pre-transplant SOS-risk assessment, SOS-severity grading, and to guide treatment.PMID:38122992 | DOI:10.1016/j.trim.2023.101975 (Source: Transplant Immunology)
Source: Transplant Immunology - December 20, 2023 Category: Transplant Surgery Authors: Denise Elb æk Horan Katrine Kielsen Sarah Wegener Weischendorff Maria Ebbesen S ørum Marte B Kammersgaard Marianne Ifversen Claus Nielsen Lars P Ryder P är I Johansson Klaus M üller Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Expression of concern: "Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells" [Transplant Immunology, Volume 75, December 2022, 101708]
Transpl Immunol. 2023 Dec;81:101879. doi: 10.1016/j.trim.2023.101879. Epub 2023 Jun 28.NO ABSTRACTPMID:38061835 | DOI:10.1016/j.trim.2023.101879 (Source: Transplant Immunology)
Source: Transplant Immunology - December 7, 2023 Category: Transplant Surgery Source Type: research
Microvascular activation and exocytosis after exposure to the serum from mismatched recipients by using donor microvascular cultures
CONCLUSIONS: This bioassay enables us to detect the activation and exocytosis of donor MVEC elicited by respective sera from mismatched kidney recipients.PMID:38013122 | DOI:10.1016/j.trim.2023.101963 (Source: Transplant Immunology)
Source: Transplant Immunology - November 28, 2023 Category: Transplant Surgery Authors: Qiang Sebastian Shi Xin Jiang Ming Li Jun Fang Zhiqiang Fu Shengyi Zhu Chengyu Wu Qianghe Meng Tun Jie Medhat Askar Source Type: research
